Fig. 4From: Development of a dual energy CT based model to assess response to treatment in patients with high grade serous ovarian cancer: a pilot cohort studyPercentage change as per RECIST/DECT-iodine concentration/CA125 criteria aligned with duration of response (months) for each relapsed patient. A) RECIST response, B) DECT- iodine concentration response, where 15% increase/reduction in concentration is designated a ‘response’ and C) GCIG CA125 responseBack to article page